Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Cash from Financing Activities (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Cash from Financing Activities for 7 consecutive years, with $168.3 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 202673.49% to $168.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $168.7 million through Dec 2025, up 6042.28% year-over-year, with the annual reading at $168.7 million for FY2025, 6042.28% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $168.3 million at Fulcrum Therapeutics, up from $64000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $168.3 million in Q4 2025, with the low at $64000.0 in Q3 2025.
  • Average Cash from Financing Activities over 5 years is $31.1 million, with a median of $506000.0 recorded in 2024.
  • The sharpest move saw Cash from Financing Activities plummeted 99.68% in 2021, then skyrocketed 202673.49% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $891000.0 in 2021, then crashed by 75.53% to $218000.0 in 2022, then soared by 31.65% to $287000.0 in 2023, then tumbled by 71.08% to $83000.0 in 2024, then surged by 202673.49% to $168.3 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $168.3 million, $64000.0, and $301000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.